Skip to content
OpenCapital
Get started

Regenxbio RGNX Enterprise value

Enterprise value at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.42B+18.1%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$2.02B-67.2%
Biogen logo
BiogenBIIB
$30.08B+34.9%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$9.22B-29.3%
EyePoint, Inc. logo
EyePoint, Inc. EYPT
$1.02B+228%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.83B-51.1%

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
P/S6×+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Calculated from Regenxbio’s reported figures.

$432.5Mmarket cap+$71.1Mtotal debt−$15.2Mcash and equivalents=$488.35M

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's enterprise value?
Regenxbio (RGNX) reported enterprise value of $488.35M in Q1 2026.
How has Regenxbio's enterprise value changed year-over-year?
Regenxbio's enterprise value increased by 58.6% year-over-year, from $307.86M to $488.35M.
What is the long-term trend for Regenxbio's enterprise value?
Over 5 years (2020 to 2025), Regenxbio's enterprise value has grown at a -14.4% compound annual growth rate (CAGR), from $1.67B to $768.01M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.